{"product_id":"2025-contemporary-issues-in-breast-pathology-uscap-videos-slides","title":"2025 Contemporary Issues in Breast Pathology (USCAP) (Videos + Slides)","description":"\u003ch4\u003eOriginal release date:July 28, 2025\u003c\/h4\u003e\n\u003ch4\u003eCourse Description\u003c\/h4\u003e\n\u003cp\u003eThis course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized.\u003c\/p\u003e\n\u003ch4\u003eTarget Audience\u003c\/h4\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003ch4\u003eLearning Objectives\u003c\/h4\u003e\n\u003cp\u003eUpon completion of this educational activity, learners will be able to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies\u003c\/li\u003e\n\u003cli\u003eDiscuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis\u003c\/li\u003e\n\u003cli\u003eDiscuss prognostic and predictive assays in patients with breast cancer\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eContinuing Medical Education\u003c\/h4\u003e\n\u003cp\u003eThe United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\u003c\/p\u003e\n\u003cp\u003eThe United States and Canadian Academy of Pathology designates this enduring material for a maximum of 19 \u003cem\u003eAMA PRA Category 1 Credits\u003c\/em\u003e\u003csup\u003eTM\u003c\/sup\u003e. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\u003c\/p\u003e\n\u003cp\u003eUSCAP is approved by the American Board of Pathology (ABPath) to offer Lifelong Learning credits for the purpose of meeting the ABPath requirements for Continuing Certification (CC).\u003c\/p\u003e\n\u003ch4 class=\"ecommerce\" data-id=\"109483\" data-type=\"Course\"\u003eContents\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eIntraductal Proliferative Lesions - Ashley Cimino-Mathews, MD\u003c\/li\u003e\n\u003cli\u003eUpdate on Classification and Management of LCIS - Stuart Schnitt, MD\u003c\/li\u003e\n\u003cli\u003eContemporary Issues in Breast Core Needle Biopsies - Laura Collins, MD\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Small Glandular Proliferations - Laura Collins, MD\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Atypical Intraductal Proliferations - Cecily Quinn, MD, FRCPath\u003c\/li\u003e\n\u003cli\u003eInflammatory and Reactive Lesions - Cecily Quinn, MD, FRCPath\u003c\/li\u003e\n\u003cli\u003ePapillary Proliferations - Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eChallenging Fibroepithelial Lesions - Puay Hoon Tan, MD\u003c\/li\u003e\n\u003cli\u003eApocrine Proliferations - Cecily Quinn, MD, FRCPath\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Fibroepithelial lesions - Puay Hoon Tan, MD\u003c\/li\u003e\n\u003cli\u003eSpindle Cell Lesions - Cecily Quinn, MD, FRCPath\u003c\/li\u003e\n\u003cli\u003eVascular Lesions - Gregory Bean, MD, PhD\u003c\/li\u003e\n\u003cli\u003eApplications of Molecular Testing in Breast Cancer - Ashley Cimino-Mathews, MD\u003c\/li\u003e\n\u003cli\u003eClassic Triple Negative Breast Cancers, TILS and the Immune Microenvironment - Ashley Cimino-Mathews, MD\u003c\/li\u003e\n\u003cli\u003eSpecial Type Triple Negative Breast Cancers - Laura Collins, MD\u003c\/li\u003e\n\u003cli\u003eHER2 Low and ER Low Breast Cancers - Stuart Schnitt, MD\u003c\/li\u003e\n\u003cli\u003ePathologic Evaluation of Specimens After Neoadjuvant Therapy - Gregory Bean, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Spindle Cell and Vascular Lesions - Gregory Bean, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Triple Negative Breast Neoplasms - Stuart Schnitt, MD\u003c\/li\u003e\n\u003cli\u003eMucinous and Neuroendocrine Lesions - Puay Hoon Tan, MD\u003c\/li\u003e\n\u003cli\u003eSpecimen Handling and Margin Evaluation - Laura Collins, MD\u003c\/li\u003e\n\u003cli\u003eEpithelial-Myoepithelial Proliferations - Puay Hoon Tan, MD\u003c\/li\u003e\n\u003cli\u003eUncommon Clinical Scenarios - Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Mucinous Lesions and ER+ Breast Cancers - Ashley Cimino-Mathews, MD\u003c\/li\u003e\n\u003cli\u003eDigital Slides: Unusual Breast Lesions - Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eUncommon Types of Invasive Breast Cancers - Gregory Bean, MD, PhD\u003c\/li\u003e\n\u003cli\u003eContemporary Lymph Node Evaluation - Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eApplications of AI to Breast Pathology - Stuart Schnitt, MD\u003c\/li\u003e\n\u003cli\u003eFREE SECTION: Panel Discussion and Q\u0026amp;A\n\u003cdiv style=\"text-align: center;\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0733\/7728\/4236\/files\/2025-Contemporary-Issues-in-Breast-Pathology-USCAP.png?v=1763762526\" alt=\"\" style=\"margin-bottom: 16px; float: none;\"\u003e\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Doctor David","offers":[{"title":"Default Title","offer_id":49015180394670,"sku":null,"price":149.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/8179\/8062\/files\/Black_and_Beige_Simple_Book_Mockup_Instagram_Post_1.png?v=1788028924","url":"https:\/\/ebooksmedical.com\/products\/2025-contemporary-issues-in-breast-pathology-uscap-videos-slides","provider":"Ebooks Medical","version":"1.0","type":"link"}